Literature DB >> 17130421

Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT.

E Y Kim1, J H Heo, S-K Lee, D J Kim, S-H Suh, J Kim, D I Kim.   

Abstract

Thin-section noncontrast CT (NCT) can detect thrombi in large arteries and can provide a measure of thrombus composition based on Hounsfield Units (HU). A study using polyethylene tubes as a model of intracranial arteries concluded that the HUs of platelet-rich thrombi are lower than those of erythrocyte-rich thrombi. Thrombus HUs were measured by NCT in 34 patients with acute ischemic stroke before thrombolysis. Thrombi with lower HU counts were resistant to thrombolytics.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17130421     DOI： 10.1212/01.wnl.0000244492.99737.a8

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  30 in total

1.  Location of the clot and outcome of perfusion defects in acute anterior circulation stroke treated with intravenous thrombolysis.

Authors:  N Sillanpää; J T Saarinen; H Rusanen; I Elovaara; P Dastidar; S Soimakallio
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-21       Impact factor: 3.825

2.  Prediction of Stent-Retriever Thrombectomy Outcomes by Dynamic Multidetector CT Angiography in Patients with Acute Carotid T or MCA Occlusions.

Authors:  K M Thierfelder; W H Sommer; B Ertl-Wagner; S E Beyer; F G Meinel; W G Kunz; G Buchholz; M F Reiser; H Janssen
Journal:  AJNR Am J Neuroradiol       Date:  2016-02-11       Impact factor: 3.825

3.  Thrombus volume comparison between patients with and without hyperattenuated artery sign on CT.

Authors:  E Y Kim; E Yoo; H Y Choi; J W Lee; J H Heo
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

Review 4.  Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review.

Authors:  Waleed Brinjikji; Sharon Duffy; Anthony Burrows; Werner Hacke; David Liebeskind; Charles B L M Majoie; Diederik W J Dippel; Adnan H Siddiqui; Pooja Khatri; Blaise Baxter; Raul Nogeuira; Matt Gounis; Tudor Jovin; David F Kallmes
Journal:  J Neurointerv Surg       Date:  2016-05-10       Impact factor: 5.836

5.  Utility of single-energy and dual-energy computed tomography in clot characterization: An in-vitro study.

Authors:  Waleed Brinjikji; Gregory Michalak; Ramanathan Kadirvel; Daying Dai; Michael Gilvarry; Sharon Duffy; David F Kallmes; Cynthia McCollough; Shuai Leng
Journal:  Interv Neuroradiol       Date:  2017-01-01       Impact factor: 1.610

Review 6.  What is meant by "TICI"?

Authors:  J E Fugate; A M Klunder; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

7.  Thrombus perviousness is not associated with first-pass revascularization using stent retrievers.

Authors:  Jun-Soo Byun; Patrick Nicholson; Christopher A Hilditch; Anderson Chun On Tsang; Vitor Mendes Pereira; Timo Krings; Yibin Fang; Waleed Brinjikji
Journal:  Interv Neuroradiol       Date:  2019-02-04       Impact factor: 1.610

8.  Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.

Authors:  Sara Martinez de Lizarrondo; Clément Gakuba; Bradley A Herbig; Yohann Repessé; Carine Ali; Cécile V Denis; Peter J Lenting; Emmanuel Touzé; Scott L Diamond; Denis Vivien; Maxime Gauberti
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

9.  Imaging Biomarkers for Intra-arterial Stroke Therapy.

Authors:  Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo
Journal:  Cardiovasc Eng Technol       Date:  2013-12-01       Impact factor: 2.495

10.  Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis.

Authors:  Stefano Forlivesi; Paolo Bovi; Giampaolo Tomelleri; Nicola Micheletti; Monica Carletti; Giuseppe Moretto; Manuel Cappellari
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.